New stent study aims to keep leg arteries open and prevent amputations

NCT ID NCT04110327

First seen Jun 26, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study is following 300 people with peripheral artery disease who received the MicroStent, a small mesh tube placed in leg arteries to improve blood flow. Researchers are tracking how well the arteries stay open over time and whether patients avoid major complications like amputation or the need for additional procedures. The goal is to see how the stent performs in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MicroStent peripheral vascular stent system (a small mesh tube placed in leg arteries to keep them open)

What this could lead to

If successful, this study could confirm that the MicroStent is a safe and effective option for treating blocked leg arteries, helping people with peripheral artery disease avoid amputation.

What could go wrong

This is an observational study, not a randomized trial, so results may be less definitive. The device is already approved for use, so this study is mainly gathering real-world data rather than testing a new breakthrough.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

limb ischemia peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • A.Z. Sint-Blasius

    Dendermonde, Belgium

  • Klinikum Hochsauerland - Karolinen Hospital

    Arnsberg, Germany

  • Maria Cecilia Hospital

    Cotignola, Italy

  • OLV Hospital

    Aalst, Belgium

  • Policlinico Abano Terme

    Abano Terme, Italy

  • St. Antonius Ziekenhuis

    Nieuwegein, Netherlands

  • Univ.-Klinikum LKH Graz

    Graz, Austria

  • University Heart Center Freiburg - Bad Krozingen

    Bad Krozingen, Germany

  • University of Leipzig

    Leipzig, Germany

  • ZOL Genk

    Genk, Belgium